Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wallentin

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
European Journal of Clinical Investigation|December 1, 1978
Lecithin: cholestrol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type IIa hyperlipoproteinaemiaL Wallentin
Atherosclerosis|September 1, 1978
Lecithin:cholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and clofibrate treatment of hypertriglyceridemic subjectsL Wallentin
Cardiovascular Research|February 1, 1997
Unstable coronary artery disease--need for long-term antithrombotic treatment. Aspirin alone is not sufficient, I would associate an anticoagulantL Wallentin
Expert Opinion on Investigational Drugs|November 4, 2000
Low molecular weight heparin in unstable coronary artery diseaseL Wallentin
Lakartidningen|July 10, 1998
[A new series: coronary vessels. Good strategy saves more patients with acute coronary syndrome]L Wallentin
Lakartidningen|October 28, 1992
[Myocardial infarction--important field for control of quality of health care and therapeutic results]L Wallentin
European Heart Journal|October 1, 1996
Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromesL Wallentin
Scandinavian Cardiovascular Journal : SCJ|May 18, 2000
Implications of the FRISCII trial: initial medical stabilization followed by an early invasive approach is the preferred strategy in unstable coronary syndromesL Wallentin
Clinical Cardiology|February 19, 2000
Long-term management--the way forward?L Wallentin
American Heart Journal|January 29, 2000
Efficacy of low-molecular-weight heparin in acute coronary syndromesL Wallentin
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
European Journal of Clinical Investigation|December 1, 1978
Lecithin: cholestrol acyl transfer rate and high density lipoproteins in plasma during dietary and cholestyramine treatment of type IIa hyperlipoproteinaemiaL Wallentin
Atherosclerosis|September 1, 1978
Lecithin:cholesterol acyl transfer rate and high density lipoproteins in plasma during dietary and clofibrate treatment of hypertriglyceridemic subjectsL Wallentin
Cardiovascular Research|February 1, 1997
Unstable coronary artery disease--need for long-term antithrombotic treatment. Aspirin alone is not sufficient, I would associate an anticoagulantL Wallentin
Expert Opinion on Investigational Drugs|November 4, 2000
Low molecular weight heparin in unstable coronary artery diseaseL Wallentin
Lakartidningen|July 10, 1998
[A new series: coronary vessels. Good strategy saves more patients with acute coronary syndrome]L Wallentin
Lakartidningen|October 28, 1992
[Myocardial infarction--important field for control of quality of health care and therapeutic results]L Wallentin
European Heart Journal|October 1, 1996
Low molecular weight heparins: a valuable tool in the treatment of acute coronary syndromesL Wallentin
Scandinavian Cardiovascular Journal : SCJ|May 18, 2000
Implications of the FRISCII trial: initial medical stabilization followed by an early invasive approach is the preferred strategy in unstable coronary syndromesL Wallentin
Clinical Cardiology|February 19, 2000
Long-term management--the way forward?L Wallentin
American Heart Journal|January 29, 2000
Efficacy of low-molecular-weight heparin in acute coronary syndromesL Wallentin
Pageof 19